Skip to content

Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00835133
Enrollment
1122
Registered
2009-02-03
Start date
2002-08-01
Completion date
2027-09-30
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial Pancreatic Cancer

Keywords

family, history, pancreas, cancer, melanoma, genetic

Brief summary

RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.

Detailed description

OBJECTIVES: * To collect clinical history, family history, and blood and/or tissue samples from family members of patients diagnosed with pancreatic diseases, pancreatic cancer, or melanoma. * To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers. OUTLINE: Study participants undergo collection of blood and/or tissue samples as well as survey data for inclusion in a familial data and tissue registry. Participants complete two baseline surveys regarding their personal, family, health, and environmental exposure histories and regarding their opinions on cancer and cancer screening. Patients also complete a follow-up survey at 1 year and undergo review of their medical records.

Interventions

OTHERbiologic sample preservation procedure

one blood sample

OTHERmedical chart review

confirmation of cancer diagnosis

OTHERsurvey administration

at baseline enrollment and 12 months post-enrollment

Sponsors

Mayo Clinic
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

DISEASE CHARACTERISTICS: * Meets 1 of the following criteria: * Has at least 2 blood relatives with pancreatic cancer (both must be related) * Has at least 1 blood relative with pancreatic cancer and 1 with melanoma (both must be related) PATIENT CHARACTERISTICS: * Mentally competent and able to provide informed consent * Able to understand and read English PRIOR CONCURRENT THERAPY: * Not specified

Design outcomes

Primary

MeasureTime frame
Collection of familial data and biospecimens in a data and tissue repository for familial pancreas researchbaseline

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORShounak Majumder, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026